During the past decade, Retina Center of Texas conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retina Center of Texas" #1 collaborator was "Juvenile Diabetes Research Foundation" with 1 trials as a collaborator, "Kowa Company, Ltd." with 1 trials as a collaborator, "National Eye Institute (NEI)" with 1 trials as a collaborator, "National Institutes of Health (NIH)" with 1 trials as a collaborator and "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Retina Center of Texas" are "Diabetic Macular Edema" (3 trials), "Diabetic Retinopathy" (2 trials), "Geographic Atrophy" (1 trials), "Macular Degeneration" (1 trials) and "Macular Telangiectasia Type 2" (1 trials). Many other conditions were trialed in "Retina Center of Texas" in a lesser frequency.

Most popular intervention types in "Retina Center of Texas" are "Drug" (4 trials), "Procedure" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham" (2 trials), "Bevacizumab + Deferred Aflibercept Group" (1 trials), "Deferred aflibercept" (1 trials), "Deferred laser" (1 trials) and "NT-501" (1 trials). Other intervention names were less common.

The vast majority of trials in "Retina Center of Texas" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Retina Center of Texas". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Retina Center of Texas, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Retina Center of Texas, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".